| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.42 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.36 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.21 | 2e-05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.2 | 5e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.19 | 5e-05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.18 | 8e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |